MONITORING OF CHIMERISM IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION BY QUANTITATIVE ASSESSMENT: THE BEST TOOL FOR MONITORING OF MINIMAL RESIDUAL DISEASE?

被引：0
|
作者：
Bouvier, A. [1 ]
Thepot, S. [2 ]
Francois, S. [2 ]
Guardiola, P. [3 ]
Tanguy-Schmidt, A. [2 ]
Beucher, A. [1 ]
Genevieve, F. [1 ]
Hunault-Berger, M. [2 ]
Zandecki, M. [1 ]
Ifrah, N. [2 ]
Blanchet, O. [1 ]
机构：
[1] CHU Angers, Hematol Lab, Angers, France
[2] CHU Angers, Serv Malad Sang, Angers, France
[3] CHU Angers, Plateforme STE, Angers, France
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1417
引用
收藏
页码：553 / 554
页数：2
相关论文
共 50 条
  • [31] QUANTITATIVE MONITORING OF WT1 GENE EXPRESSION IN PERIPHERAL BLOOD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA - AN USEFUL TOOL FOR EARLY DETECTION OF MINIMAL RESIDUAL DISEASE
    Polak, J.
    Valkova, V.
    Vitek, A.
    Hajkova, H.
    Markova, M.
    Salek, C.
    Cetkovsky, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 213 - 213
  • [32] Monitoring of Wilms' Tumor 1 Expression As Minimal Residual Disease in Patients with Acute Myeloid Leukemia to Predict Relapse before and after Allogeneic Stem Cell Transplantation
    Dulery, Remy
    Nibourel, Olivier
    Elsermans, Vincent
    Beauvais, David
    Simonnet, Arthur
    Gauthier, Jordan
    Coiteux, Valerie
    Magro, Leonardo
    Quesnel, Bruno
    Preudhomme, Claude
    Yakoub-Agha, Ibrahim
    BLOOD, 2014, 124 (21)
  • [33] Universal monitoring of minimal residual disease in acute myeloid leukemia
    Coustan-Smith, Elaine
    Song, Guangchun
    Shurtleff, Sheila
    Yeoh, Allen Eng-Juh
    Chng, Wee Joo
    Chen, Siew Peng
    Rubnitz, Jeffrey E.
    Pui, Ching-Hon
    Downing, James R.
    Campana, Dario
    JCI INSIGHT, 2018, 3 (09)
  • [34] Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
    Fan, Shuang
    Shen, Meng-Zhu
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Wang, Yu
    Yan, Chen-Hua
    Chen, Huan
    Chen, Yu-Hong
    Han, Wei
    Wang, Feng-Rong
    Wang, Jing-Zhi
    Zhao, Xiao-Su
    Qin, Ya-Zhen
    Chang, Ying-Jun
    Liu, Kai-Yan
    Huang, Xiao-Jun
    Mo, Xiao-Dong
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [35] Combination of Minimal Residual Disease By Flow Cytometry before and after Hematopoietic Stem Cell Transplantation Predicts Survival in Patients with Acute Myeloid Leukemia
    Nunez-Torron, Claudia
    Jimenez, Carlos
    Moro, Fernando Martin
    Marquet, Juan
    Piris-Villaespesa, Miguel
    Hernandez, Clara Lopez
    Luna, Alejandro
    Gutierrez Sr, Valentin Garcia
    Chinea, Anabelle
    Jimenez, Maria Gemma Moreno
    Lopez, Javier
    Puente, Pilar Herrera
    BLOOD, 2024, 144 : 7445 - 7446
  • [36] Outcome and Minimal Residual Disease Monitoring in Patients with t(16;21) Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Qin, Ya-Zhen
    Chen, Yao
    Xu, Lan-Ping
    Wang, Yu
    Zhang, Xiao-Hui
    Chen, Huan
    Zhao, Xiao-Su
    Liu, Kai-Yan
    Huang, Xiao-Jun
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (01) : 163 - 168
  • [37] QUANTITATIVE ASSESSMENT OF WT1 EXPRESSION: A USEFUL TOOL FOR MONITORING MINIMAL RESIDUAL DISEASE IN ACUTE LEUKEMIA PATIENTS
    Salmi, F.
    Ottaviani, E.
    Papayannidis, C.
    Paolini, S.
    Lama, B.
    Cilloni, D.
    Messa, F.
    Testoni, N.
    Vianelli, N.
    Finelli, C.
    Iacobucci, I.
    Baccarani, M.
    Martinelli, G.
    Curti, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 117 - 118
  • [38] Molecular monitoring of chimerism and minimal residual disease in multiple myeloma patients after non-myeloablative stem cell transplantation
    Galimberti, S
    Benedetti, E
    Fazzi, R
    Papineschi, F
    Caracciolo, F
    Orciuolo, E
    Andreazzoli, F
    Morabito, F
    Cuzzola, M
    Martino, M
    Iacopino, P
    Petrini, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S112 - S112
  • [39] Molecular-cytogenetic monitoring of chimerism and minimal residual disease in patients with chronic myeloid leukemia after allogenic and syngenic transplantation of bone marrow
    Vinogradova, OA
    Savchenko, VG
    Domracheva, EV
    Lyubimova, LS
    Olshanskaya, YV
    Dyachenko, LV
    Parovichnikova, EN
    Mendeleeva, LP
    Zakharova, AV
    TERAPEVTICHESKII ARKHIV, 2002, 74 (07) : 38 - 44
  • [40] Next-generation sequencing-based minimal residual disease monitoring in patients receiving allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia or myelodysplastic syndrome
    Shapiro, Roman M.
    Kim, Dennis Dong Hwan
    CURRENT OPINION IN HEMATOLOGY, 2018, 25 (06) : 425 - 432
12345